BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
11.62
-0.27 (-2.27%)
Oct 7, 2026, 9:33 AM EDT - Market open
BrainsWay Employees
BrainsWay had 129 employees as of December 31, 2025. The number of employees increased by 9 or 7.50% compared to the previous year.
Employees
129
Change (1Y)
9
Growth (1Y)
7.50%
Revenue / Employee
$470,504
Profits / Employee
$73,186
Market Cap
469.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 129 | 9 | 7.50% |
| Dec 31, 2024 | 120 | -14 | -10.45% |
| Dec 31, 2023 | 134 | 0 | - |
| Dec 31, 2022 | 134 | 16 | 13.56% |
| Dec 31, 2021 | 118 | 18 | 18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tactile Systems Technology | 1,086 |
| OrthoPediatrics | 602 |
| SS Innovations International | 483 |
| Cerus | 275 |
| AVITA Medical | 226 |
| NeuroPace | 220 |
| Sight Sciences | 186 |
| 908 Devices | 172 |
BWAY News
- 4 weeks ago - BrainsWay Reports Positive Pilot Study Results For Deep TMS In Depression & Early Alzheimer's - Nasdaq
- 4 weeks ago - Brainsway publishes results from pilot study - TheFly
- 4 weeks ago - BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer's Disease Treated with Deep TMS™ - GlobeNewsWire
- 5 weeks ago - Brainsway price target raised to $19 from $17 at H.C. Wainwright - TheFly
- 5 weeks ago - Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High? - Nasdaq
- 7 weeks ago - Brainsway (BWAY) Upgraded to Buy: Here's Why - Nasdaq
- 7 weeks ago - Brainsway reports Q2 EPS 7c, consensus 7c - TheFly
- 7 weeks ago - Brainsway raises FY26 revenue view to $68M-$70M from $66M-$68M - TheFly